The impact of AD drug treatments on event-related potentials as markers of disease conversion. - Chapman RM; Porsteinsson AP; Gardner MN; Mapstone M; McCrary JW; Sandoval TC; Guillily MD; Reilly LA; DeGrush E (Current Alzheimer research, 2013)